Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial (Q70401253)
Jump to navigation
Jump to search
scientific article published on 01 September 1988
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial |
scientific article published on 01 September 1988 |
Statements
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial (English)
O Rascol
J L Montastruc
M Simonetta
1 September 1988